Protara Therapeutics, Inc. — Director's Dealing 2023

Jan 11, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Protara Therapeutics, Inc. (TARA)
CIK: 0001359931
Period of Report: 2023-01-10

Reporting Person: Zummo Jacqueline (Chf Scientific Operations Off)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-10	Common Stock	F	5225	$3.00	Disposed	71573	Direct

Footnotes

F1: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 10, 2020.